Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Brii Biosciences
company
About
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $155M
- Industries
- Biotechnology,Health Care,Innovation Management,Pharmaceutical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$415M
Brii Biosciences has raised a total of
$415M
in funding over 2 rounds. Their latest funding was raised on
Mar 23, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 23, 2021 | Series C | $155M | 1 |
Invesco
|
— | Detail |
| May 24, 2018 | Series Unknown | $260M | 1 |
ARCH Venture Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Brii Biosciences is funded by 2 investors.
Invesco
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Invesco
|
Yes | Series C |
|
ARCH Venture Partners
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
